Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 74.3
(-1.72%)
CNY 74.3
(-1.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.95 Billion CNY | 44.39% |
| 2022 | 1.35 Billion CNY | 34.81% |
| 2021 | 1 Billion CNY | 41.79% |
| 2020 | 710.28 Million CNY | 9.33% |
| 2019 | 649.69 Million CNY | 65.59% |
| 2018 | 392.34 Million CNY | 39.42% |
| 2017 | 281.4 Million CNY | 12.73% |
| 2016 | 249.62 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 507.53 Million CNY | -14.57% |
| 2024 Q3 | 713.93 Million CNY | 19.63% |
| 2024 Q2 | 596.77 Million CNY | 17.58% |
| 2023 Q4 | 594.09 Million CNY | 12.86% |
| 2023 FY | 1.96 Billion CNY | 44.39% |
| 2023 Q3 | 526.41 Million CNY | 14.89% |
| 2023 Q1 | 381.57 Million CNY | 13.41% |
| 2023 Q2 | 458.18 Million CNY | 20.08% |
| 2022 Q1 | 308.41 Million CNY | 11.97% |
| 2022 FY | 1.35 Billion CNY | 34.81% |
| 2022 Q4 | 336.44 Million CNY | -11.75% |
| 2022 Q3 | 381.23 Million CNY | 14.98% |
| 2022 Q2 | 331.56 Million CNY | 7.51% |
| 2021 Q3 | 308.61 Million CNY | 34.13% |
| 2021 Q4 | 275.44 Million CNY | -10.75% |
| 2021 Q2 | 230.08 Million CNY | 19.25% |
| 2021 Q1 | 192.95 Million CNY | -10.01% |
| 2021 FY | 1 Billion CNY | 41.79% |
| 2020 Q4 | 214.41 Million CNY | 20.01% |
| 2020 Q1 | 164.46 Million CNY | -9.63% |
| 2020 Q2 | 152.72 Million CNY | -7.14% |
| 2020 Q3 | 178.67 Million CNY | 16.99% |
| 2020 FY | 710.28 Million CNY | 9.33% |
| 2019 Q1 | 128.92 Million CNY | 5.45% |
| 2019 FY | 649.69 Million CNY | 65.59% |
| 2019 Q4 | 181.99 Million CNY | -3.48% |
| 2019 Q3 | 188.56 Million CNY | 25.53% |
| 2019 Q2 | 150.2 Million CNY | 16.51% |
| 2018 Q3 | 122.17 Million CNY | 0.0% |
| 2018 Q4 | 122.25 Million CNY | 0.07% |
| 2018 FY | 392.34 Million CNY | 39.42% |
| 2017 FY | 281.4 Million CNY | 12.73% |
| 2016 FY | 249.62 Million CNY | 0.0% |